Navigation Links
Radiotherapy Market is Expected to Grow at a Faster Rate with a CAGR of 5.3% & to Reach $5.8 Billion by 2016 - New Report by MarketsandMarkets
Date:5/10/2013

(PRWEB) May 10, 2013

The “Radiotherapy Market By Technology, Applications & Products (2011 – 2016)”, published by MarketsandMarkets analyzes and studies the major market drivers, restraints, and opportunities in the Americas, Europe, Asia, and the rest of the world including Japan.

Browse:

  • 133 Market Data Tables
  • 40 Figures &
  • 311 Pages& In-depth Table of Content on Radiotherapy Market.

http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html

Early buyers will receive 10% customization on this report.

Radiation therapy is one of the advanced treatment and diagnostic procedures to kill damaged cells using focused energy with the intention of limiting harmful effects to the neighbouring healthy cells. Radiotherapy is generally applied either alone or along with the combination of surgery or chemotherapy. The major driving force in the advancements in radiation oncology over the conventional radiotherapy is the unique therapeutic effect on genetic materials of damaged cells. Radiotherapy interrupts cell replication and eventually causes cell-death.

The global radiotherapy devices market is classified into:

  • External Radiotherapy;
  • Internal Radiotherapy (brachytherapy); and
  • Systemic Radiotherapy.

The radiation therapy market is expected to grow at a faster rate with a CAGR of 5.3% from 2011 to 2016.

The global radiotherapy market has seen challenging the dynamic market conditions, but still remains strong with a size of approximately $4.4 billion in 2011.

The worldwide market for radiotherapy devices is principally commanded by major players, such as Varian Medical System, Accuray, Inc., Elekta AB, IsoRay Medical, Inc. etc.

Buy a copy of this report @ http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=567

Find related Reports to - Medical Device Market

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Connect with us on LinkedIn
Connect with us on Facebook

Read the full story at http://www.prweb.com/releases/radiotherapy-devices/market/prweb10702736.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Palliative radiotherapy for bone metastases in elderly patients improves quality of life
2. Intensity modulated radiotherapy reduces side effects in patients with early breast cancer
3. New radiotherapy approach reduces symptoms of dry mouth in patients with head and neck cancers
4. Surgery is superior to radiotherapy in men with localized PCa, says prize-winning Swedish study
5. Promising new drug treats and protects against radiotherapy-associated oral mucositis
6. Sniffing out the side effects of radiotherapy may soon be possible
7. 1 out of 4 lung cancer patients in Andalusia does not receive the radiotherapy they need
8. Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
9. Potential new technique for anticancer radiotherapy could provide alternative to brachytherapy
10. RI Hospital researcher: Older women may not benefit from radiotherapy after breast surgery
11. Quality of life study shows stereotactic ablative radiotherapy effective treatment; stage I NSCLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Revolution for Truth has organized the ... parental rights and civil liberties, and to restore transparency within government agencies responsible ... with a press conference taking place Friday morning calling on President Trump to ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
(Date:3/28/2017)... Pittsburgh, PA (PRWEB) , ... March 28, 2017 ... ... built for and by physicians, announced today the launch of a free, public-facing ... The Via Cost Analyzer (VCA) was developed to provide comparative information to patients, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , United Kingdom and  BOSTON , March ... provider Linguamatics today announced a partnership ... . The agreement allows pharmaceutical companies to extract ... I2E text mining technology. ... 18 of the top 20 global pharmaceutical companies. ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology: